Xuerong Biotechnology(SZ:300511) Zheng Quan Zhi Xing·2025-09-04 16:22Core Viewpoint - Shanghai Xuerong Biological Technology Co., Ltd. has announced the early redemption of its convertible bonds, "Xuerong Convertible Bonds," due to the triggering of conditional redemption clauses based on stock price performance [1][2]. Group 1: Convertible Bond Redemption Announcement - The company will redeem "Xuerong Convertible Bonds" at a price of 100.93 CNY per bond, which includes accrued interest [1][8]. - The redemption is triggered as the company's stock price has been above 120% of the conversion price for 15 trading days within the specified period [2][7]. - The redemption will be completed by October 15, 2025, and the bonds will be delisted from the Shenzhen Stock Exchange thereafter [1][9]. Group 2: Convertible Bond Details - The company issued 5,850,000 convertible bonds on June 24, 2020, with a total fundraising amount of 585 million CNY [2][3]. - The conversion period for the bonds started on January 4, 2021, and will end on June 23, 2026 [3]. - The conversion price has been adjusted multiple times, with the latest adjustment setting it at 4.10 CNY per share effective from August 26, 2024 [6][7]. Group 3: Redemption Process - The redemption will be executed for all bondholders registered with China Securities Depository and Clearing Corporation Limited by the close of trading on October 14, 2025 [8][9]. - The accrued interest for the bonds is calculated based on a formula that considers the principal amount, interest rate, and the number of days since the last interest payment [8][7]. - Bondholders are advised to consult their brokerage firms regarding the conversion process before the redemption [9][10].